Loading clinical trials...
Loading clinical trials...
Modulation of Cognitive Flexibility by Transcranial Direct Current Stimulation, Tyrosine Administration and Polymorphisms in the COMT Gene
The current study would examine whether increases in endogenous dopaminergic activity via tyrosine and the (presumed) excitation of these by anodal tDCS of the dlPFC could causally be related to cognitive flexibility as measured by task switching and reversal learning. Additionally, the study will test whether the Val158Met-polymorphism in the catechol- O-methyltransferase (COMT) gene could also predict the effect of TYR supplementation, as this gene is involved in DA degradation in the prefrontal cortex.
Age
18 - 30 years
Sex
ALL
Healthy Volunteers
Yes
Psychology labs
Sheffield, South Yorkshire, United Kingdom
Start Date
February 18, 2019
Primary Completion Date
September 30, 2019
Completion Date
September 30, 2019
Last Updated
April 4, 2019
32
ESTIMATED participants
tdcs (sham/anodal) + drug (placebo/tyrosine)
COMBINATION_PRODUCT
Lead Sponsor
Sheffield Hallam University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions